Literature DB >> 2724247

Pathogenesis of discovertebral and manubriosternal joint abnormalities in rheumatoid arthritis: a cadaveric study.

J P Schils1, D Resnick, P N Haghighi, D Trudell, D J Sartoris.   

Abstract

The precise pathogenesis of discovertebral lesions in rheumatoid arthritis has long been debated with the emergence of 2 conflicting theories: discovertebral extension of synovial inflammation from a neighboring articulation (Luschka, costovertebral joint) and repetitive discal trauma with Schmorl's nodes. In order to address this controversy, we performed a radiographic-pathologic correlation of a rheumatoid cadaver and compared the alterations seen in the cervical and lumbar discovertebral junction; we further included an evaluation of the manubriosternal joint, another cartilaginous articulation. Our data confirmed that advanced discovertebral lesions in the cervical and lumbar spine are related primarily to endplate failure that itself is caused by apophyseal joint destruction and segmental spinal instability, although inflammatory rheumatoid lesions of the cervical intervertebral discs probably arising from the Luschka joints are also evident. Conversely, the lesions of the manubriosternal joint were produced by inflammatory changes related to the development of a synovial cavity in the articulation.

Entities:  

Mesh:

Year:  1989        PMID: 2724247

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

Review 1.  Update on imaging of the cervical spine in rheumatoid arthritis.

Authors:  Mostafa Ellatif; Ban Sharif; David Baxter; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2022-02-10       Impact factor: 2.199

2.  Characteristics of lumbar scoliosis in patients with rheumatoid arthritis.

Authors:  Masanobu Ohishi; Hisaaki Miyahara; Masakazu Kondo; Yasuharu Nakashima; Kazumasa Terada; Yukio Esaki; Nobuo Kobara; Katsumi Harimaya; Yoshihiro Matsumoto; Yukihide Iwamoto
Journal:  J Orthop Surg Res       Date:  2014-04-26       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.